Cancer innovation
2021 marks the 50th anniversary of the National Cancer Act of 1971 — legislation that intended to end the "war on cancer" by expanding funding and authorities to the National Cancer Institute. Half a century since the act was signed into law, NCI and the biomedical research community have made leaps and bounds in cancer research, clinical trials, diagnostics and treatment. As NCI and the country continue to fight the war on cancer today, GovernmentCIO Media & Research is collaborating with the institute to bring you a HealthCast miniseries to commemorate the National Cancer Act's impact.
The legislation set the foundation for the future of the war against cancer.
NCI’s SEER and CIS programs encourage ongoing engagement to further data sharing goals.
How NCI-designated cancer centers are supporting the national fight against cancer.
Data, communications tech, next-gen DNA sequencing and more have helped accelerate NCI's mission over the past 50 years.
In this episode of our National Cancer Act 50th anniversary miniseries, we dive into how NCI is fighting pediatric cancers.
In this latest episode of the National Cancer Act miniseries, we discuss progress in cancer prevention research and practice.
Making the fight against cancer more equitable requires diversifying cancer research, clinical trials and treatments.
Clinical trials, innovation in research, and technology have improved cancer treatment and diagnostics in public health.
We delve into the history of cancer in America and talk to NCI Director Dr. Ned Sharpless on NCI's work the past 50 years.
HealthCast dives into the history and progress of legislation that kicked off decades of cancer care research and innovation.
Cancer care innovation
Follow Us
© 2022 GovernmentCIO Magazine LLC. All rights reserved. Privacy policy.